Cerevast Therapeutics

Cerevast Therapeutics

United States
Cerevast Therapeutics, Inc. is a medical technology company with primary emphasis in the field of SonoLysis for the treatment acute ischemic stroke and other vascular disorders. This non-invasive treatment is administered with Cerevast’s proprietary ultrasonic headframe called the ClotBust-ERTM, an operator independent device that can be rapidly and easily deployed by virtually any emergency room staff to safely administer the ultrasound energy for SonoLysis therapy. Cerevast was formed in September of 2009 following the acquisition of substantially all of the assets of ImaRx Therapeutics, Inc. – a publicly traded company focused on the development of microsphere contrast agents and therapeutics. Through this acquisition, Cerevast gained title to the dominant intellectual property estate and an extensive data package of pre-clinical and clinical studies. Cerevast has assembled a management team with extensive technical, scientific, commercial and regulatory expertise. The company has also assembled a Scientific Advisory Board comprised of globally recognized clinicians, all of whom are leading experts in the field of SonoLysis, ultrasound development and stroke treatment. The company’s headquarters are located in Redmond, Washington.
Founded date
01/01/2009
# of employees
11-50
Company type
For Profit

General & financials

Estimated revenue
$1M to $10M
# of funders
Founders
Industry group
Biotechnology, Health Care, Science and Engineering

Founding

Top 5 investors
UT Horizon Fund, Haiyin Capital
# of funding runds
7
Last founding
$11.400.000
Total funded
$24.438.812

See more companies

See full list
Amethyst Radiotherapy

Amethyst Radiotherapy

Estimated revenue
$1M to $10M
# of employees
51-100
Company type
For Profit
Refocus Group

Refocus Group

Estimated revenue
$1M to $10M
# of employees
11-50
Company type
For Profit
ZyVersa Therapeutics

ZyVersa Therapeutics

Estimated revenue
$1M to $10M
# of employees
11-50
Company type
For Profit
AbilTo

AbilTo

Estimated revenue
$1M to $10M
# of employees
101-250
Company type
For Profit
Eureka93

Eureka93

Estimated revenue
$1M to $10M
# of employees
51-100
Company type
For Profit
Axio Biosolutions

Axio Biosolutions

Estimated revenue
$10M to $50M
# of employees
101-250
Company type
For Profit
Health Hero Network

Health Hero Network

Estimated revenue
$10M to $50M
# of employees
101-250
Company type
For Profit
Droplette

Droplette

Estimated revenue
$1M to $10M
# of employees
11-50
Company type
For Profit

How to get access to the full list?

Duplicate this list

Get access to a comprehensive list of companies with their industries, location and contacts infos.

Prepare outreach

Drafting good emails makes you more likely to get get results.

Track & Follow

Keeping momentum by managing all your angel investors prospects in a pipeline with pre-set stages: "contacted", "replied", "in discussion" for ex. Follow-up tightly, close in time.

What is folk?

folk is a lightweight and easy-to-use CRM that you can leverage to build lists of contacts and manage your processes with these contacts.

How to get access to this list of companies?

You can simply duplicate the list. You will need to create a folk account in order to duplicate the list properly.

What can I do with the list after duplicating it? 

On folk, you can directly email these companies and manage them in a pipeline board.